Cite
HARVARD Citation
Tontsch-Grunt, U. et al. (n.d.). Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML. European journal of cancer. pp. S89-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tontsch-Grunt, U. et al. (n.d.). Combination of the novel BET inhibitor BI 894999 with CDK9 inhibition suggests a promising regimen for the treatment of AML. European journal of cancer. pp. S89-. [Online].